Latest News about MRK
Recent news which mentions MRK
From InvestorPlace
Medicare's Ambitious Drug Price Negotiation Plan: President Joe Biden Calls To Expand Targeted Medicines To 50 Annually by 2029
March 07, 2024
From Benzinga
Promising HIV Treatment: Phase 2 Clinical Trial Success for Gilead's and Merck's Combo Therapy
March 06, 2024
From Benzinga
Biogen's Spinraza For Muscle Movement Disorder Shows Improved Motor Function In Infants, Toddlers
March 06, 2024
From Benzinga
Biden's State Of The Union: Grading His Results On Abortion Access, Drug Prices And Opium Epidemic
March 05, 2024
From Benzinga
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
March 05, 2024
From Benzinga
The Top 3 Dow Stocks to Buy in March 2024
March 04, 2024
From InvestorPlace
3 Magnificent Growth Stocks to Buy in March
March 02, 2024
From Motley Fool
From Benzinga
7 Timeless Stocks to Invest in for 2024
March 01, 2024
From InvestorPlace
Critical Insights From Merck & Co Analyst Ratings: What You Need To Know
February 29, 2024
Tickers
MRK
From Benzinga
A Bull Market Is Here: 2 Magnificent Stocks Down 80% to Buy Right Now
February 29, 2024
From Motley Fool
From Benzinga
From Benzinga
3 Long-Term Winners from Charles Schwab’s Top Picks
February 27, 2024
From InvestorPlace
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
February 26, 2024
From Benzinga
3 Top Pharma Stocks for Investors Betting on a Biotech Boom
February 26, 2024
From InvestorPlace
3 Undervalued Small-Cap Stocks to Add to Your Must-Buy List
February 22, 2024
From InvestorPlace
Outdoing Cancer Requires Pharma To Go Beyond Merely Revolutionizing Existing Treatment
February 22, 2024
From Benzinga
2 Monster Stocks to Buy Without Any Hesitation
February 22, 2024
From Motley Fool
Recession's Shadow Casts Doubt On Soft Landing: Safeguard Your Portfolio With These Stocks
February 16, 2024
From Benzinga
3 Inflation-Proof Stock Picks Following Tuesday’s CPI Report
February 15, 2024
From InvestorPlace
Exploring The Competitive Space: Merck & Co Versus Industry Peers In Pharmaceuticals
February 14, 2024
From Benzinga
This United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
February 12, 2024
From Benzinga
2 Value Stocks With Monster Yields
February 12, 2024
From Motley Fool
Bernie Sanders Blasts Big Pharma's Pricing Of Lifesaving Drugs In US During Senate Hearing On Medicare
February 09, 2024
From Benzinga
Here's Why Merck, Eli Lilly, and Novo Nordisk Stocks Rose 11% Last Month
February 08, 2024
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.